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THANK YOU, ladies and gentlemen, and especially Jean Borel. I am honored to be here, and especially by 
the chance to speak. More than a retirement banquet, we 
celebrate tonight and tomorrow the descent of a hero from 
Mt. Olympus. How you, Jean Borel, managed to scale such 
heights, and returned unscathed is a question to which I will 
return in a moment. But first, I want to say something about 
what your journey meant to me personally, and eventually 
to everyone else in this room, and in the world, 
In the 5 years between 1962 and 1967, an empirical 
foundation was laid for clinical organ transplantation, using 
chemical immunosuppression based on azathioprine and 
prednisone, with or without ALG. This was at first a time of 
wild and frequently unwarranted enthusiasm, which was 
then succeeded by a dozen years of deepening despair. The 
I-year survival of cadaver kidney grafts through the 1970s 
remained frozen at 50%, and even in successful cases, this 
kind of treatment was more like a disease than a cure. 
Although long survival after liver, lung, heart, and pancreas 
transplantation was first accomplished in humans during 
1967, the results with these organs were even more dismal 
than with the kidney. Instead of burgeoning, the new field 
of transplantation was undergoing quiet atrophy. 
The primary victims always were the disillusioned pa-
tients. Those whose desperate gamble ostensibly paid off in 
terms of survival all too often found themselves returning to 
a hopelessly eroded quality of posttransplantation life. 
Surgeons who were attempting to offer transplantation 
services with extrarenal organs-including me, Roy Caine, 
Norm Shumway, Dick Lillehei, and others-found our-
selves under siege by our own professional colleagues. Like 
prisoners in the confines of a self-made dungeon, we tapped 
increasingly feeble messages of hope to each other, all the 
while wondering if ours was to be a life sentence of 
frustration. 
At the darkest and most unexpected moment, a mounted 
torch-bearer appeared in the distance. The torch was 
cyclosporine; the bearer was Jean Sore\. and the horse was 
the Sandoz Corporation. How the next steps were taken by 
Roy Caine and his English colleagues is the material of 
legends. Suffice it to say, both the patients and those who 
cared for them were liberated from a terrible bondage. 
There have been improvements in treatment since then, 
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and there will be more. None, in my opinion, will compare 
in magnitude to those that occurred between 1978 and 1980 
as the result of Jean Borel's initiative. 
How could a single person have such an impact, partic-
ularly in this modern era in which individual scientists are 
increasingly viewed as mere cogs in a multidisciplinary 
research machine? I learned the answer when I saw an 
advanced copy of Jean Borel's remarks, which you have 
heard tonight. If you listened carefully, you will have 
appreciated the deeply personal conflict that still haunts 
Jean Borel, resulting from the enforced abandonment at an 
early age of his first love (art). Although the decision to 
enter science was imposed by practical considerations, the 
lessons already learned by his humanities background were 
always just around the corner. 
In protest, as a child and young man, he obliterated in his 
inner life the distinction between art and science. That 
allowed him to exercise the imagination and creativity of 
the artist in the pursuit of science. The result was vision. 
Instead of believing that scientists should be just as method-
ical and as plodding as accountants, his conviction was that 
first-rate science required the same imagination as art. In 
both, it was necessary to strive for authenticity and intensity 
of feeling, even heroism and sacrifice. 
These expressions of individuality allowed him to see and 
create things far beyond the reach of comfortable Philis-
tines. Rather than focusing on details, he saw the whole 
canvas. This was the man who went to England in 1977, not 
to give a research paper to a group of immunologists, but to 
accomplish a multifaceted mission that included human 
service. Completion of the mission, which he saw through, 
was central to the revolution that has occurred in transplan-
tation, and as the ripple effects played out, in all of 
immunology. 
When something like this happens. we should (in fact we 
must) look at the responsible individuals beyond the tradi-
tional bestowal of much deserved accolades and honors. 
What made such people what they came to be? If only we 
knew, we would have the means by which it could be made 
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to happen again in generations yet to come. 1•2 As for Jean 
Borel, don't count him out. There are pictures to be 
painted, music to be composed, and words to be written. 
And there is still plenty of time. 
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